Tandem Diabetes Care (NASDAQ: TNDM) experienced a significant stock increase of over 32% after reporting substantial gains in profitability for the fourth quarter. The company’s new pay-as-you-go pharmacy structure is driving margin expansion and recurring revenue, with gross margin improving to 58%. Management anticipates continued profitable growth and expects full-year sales for 2026 to be between $1.065 billion and $1.085 billion.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Why Tandem Diabetes Care Stock Popped Today
Tandem Diabetes Care (NASDAQ: TNDM) experienced a significant stock increase of over 32% after reporting substantial gains in profitability for the fourth quarter. The company’s new pay-as-you-go pharmacy structure is driving margin expansion and recurring revenue, with gross margin improving to 58%. Management anticipates continued profitable growth and expects full-year sales for 2026 to be between $1.065 billion and $1.085 billion.